DorsaVi bags UK deal
Published 29-JAN-2016 09:28 A.M.
|
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Medical device company DorsaVi (ASX:DVL) has bagged a third contract with the London Underground rail network as the operators of one of the world’s largest transport systems try to solve an OH&S riddle.
The ASX-listed outfit is responsible for “ViSafe” technology, which is a series of sensors which can be applied to workers to help analyse how they are moving throughout the day.
With the motion data captured, DVL is then able to generate insights into which actions could be causing stress to the body and which tasks could lead to injury.
The latest contract with Transport for London, operator of the London Underground, is for £100,000 ($A202,768).
It will apply the sensors to its workers to help figure out how to better work in a way which lessens the chances of workers getting musculoskeletal injuries.
In particular, Transport of London will be measuring stress to workers’ lower backs and shoulders while train drivers will be measured for the impact vibration of the train has on their muscles.
According to DVL, the UK Health and Safety Executive showed that 9.5 million working hours were lost in the 2015 financial year due to musculoskeletal injury, with manual handling work the main culprit.
More than half a million of these were injuries sustained in the workplace.
DVL is hoping its tech will allow employers to get a better idea of how their workers could potentially be injured while on the job, with the data to inform better work practices to lessen lost time due to injury.
“It’s great to see the transport sector embracing innovative technologies to reduce risk and improve productivity,” Zoe Whyatt from DorsaVi’s European office said.
“Wearable tech is dominating the health and leisure market and ViSafe has packaged powerful and highly sophisticated movement technology into miniature wireless sensors that allow data to be captured in the field in real time.”
About DorsaVi (ASX:DVL)
DorsaVi (ASX:DVL) is an ASX company focused on developing innovative motion analysis device technologies for use in elite sports, occupational health and safety, and clinical applications.
DorsaVi believes its wearable sensor technology enables – for the first time – many aspects of detailed human movement and position to be accurately captured, quantified and assessed outside a biomechanics lab, in both real-time and real situations for up to 24 hours.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.